-
1
-
2
Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier
Published 2025-05-01Get full text
Article -
3
Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApollo
Published 2024-12-01Get full text
Article -
4
-
5
Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinationsResearch in context
Published 2025-08-01“…Funding: This work was performed at, and funded by Genentech Inc. South San Francisco, CA 94080, USA.…”
Get full text
Article -
6
-
7
Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapy
Published 2025-07-01Get full text
Article -
8
Characterization of free light chain impurity in a bispecific antibody
Published 2025-12-01Get full text
Article -
9
COP1 Deficiency in BRAF<sup>V600E</sup> Melanomas Confers Resistance to Inhibitors of the MAPK Pathway
Published 2025-06-01Get full text
Article -
10
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies
Published 2024-12-01Get full text
Article -
11
-
12
-
13
Author Correction: Proteomics approach identifies aqueous humor biomarkers in retinal diseases
Published 2025-06-01Get full text
Article -
14
Membrane display and functional analysis of juxtacrine ligand-receptor signaling
Published 2015-10-01Get full text
Article -
15
-
16
-
17
-
18
MHC2-SCALE enhances identification of immunogenic neoantigens
Published 2025-04-01Get full text
Article -
19
YAP/TAZ activity in PDGFRα-expressing alveolar fibroblasts modulates AT2 proliferation through Wnt4
Published 2025-05-01Get full text
Article -
20
Combining Fundamental Kinetics and Standard Alkylation Assays to Prioritize Lead-Like KRAS G12C Inhibitors
Published 2024-12-01Get full text
Article